Literature DB >> 3044345

Factor XIII: enzymatic and clinical aspects.

H E Karges1, R Clemens.   

Abstract

The present knowledge about clotting F XIII is roughly displayed. It is explained why F XIII is not a clotting factor in the strict sense of the word and that its biological function more general is the crosslinking of proteins via a transamidase reaction, the reduction of the permeability of the microvasculature, the stimulation of connective tissue cells, and finally the steering of connective tissue processes involved in wound healing. These effects are demonstrated as well in cell culture studies, animal experiments as by clinical results. Concerning the clinical results with F XIII, its effects on sclerodermia, subarachnoidal hemorrhage, inflammatory bowel diseases, Purpura Schönlein Henoch, and the wound healing are described in more detail.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044345

Source DB:  PubMed          Journal:  Behring Inst Mitt        ISSN: 0301-0457


  3 in total

1.  Effect of factor XIII on endothelial barrier function.

Authors:  T Noll; G Wozniak; K McCarson; A Hajimohammad; H J Metzner; J Inserte; W Kummer; F W Hehrlein; H M Piper
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

2.  Plasmatic [corrected] factor XIII reduces severe pleural effusion in children after open-heart surgery.

Authors:  M Schroth; U Meißner; R Cesnjevar; M Weyand; H Singer; W Rascher; J Klinge
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

3.  Expression of the human blood coagulation protein factor XIIIa in Saccharomyces cerevisiae: dependence of the expression levels from host-vector systems and medium conditions.

Authors:  M Bröker; O Bäuml; A Göttig; J Ochs; M Bodenbenner; E Amann
Journal:  Appl Microbiol Biotechnol       Date:  1991-03       Impact factor: 4.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.